Key result
Cyclosporine treatment in corneal graft recipients increased systolic and diastolic blood pressures and systolic blood pressure variability, pointing to a direct vascular effect.
Why the study?
Does cyclosporine treatment affect autonomic cardiovascular control and blood pressure in patients undergoing corneal transplantation?
Observational (n=8)
Does cyclosporine treatment affect autonomic cardiovascular control and blood pressure in patients undergoing corneal transplantation?
Cyclosporine-induced hypertension in corneal transplant recipients appears to result from a direct vascular effect rather than sympathetic activation, while normal cardiac baroreflex function is maintained.
Answers are grounded in this paper and cite their sources.
Cyclosporine was associated with higher BP and variability in corneal recipients; supports direct vascular mechanism but leaves open need for confirmation.
Loss of autonomic cardiovascular homoeostasis is often suspected in hypertension that has developed after organ transplantation. We serially assessed autonomic cardiovascular control in eight patients in generally good condition who needed cyclosporine (CyA) treatment because of high risk of rejection in corneal transplantation. To this aim, we investigated the patients, before and while they were receiving CyA, for 1 week and at 1, 3 and 6 months. For each period, spontaneous baroreflex, blood pressure, heart rate and variability were assessed, as well as neuro-hormonal indicators, while the patients were in both supine and 60 degrees upright positions. After 1 week of treatment, patients showed increases in systolic, diastolic and pulse blood pressures (P<0.05) that were concomitant with a transient decrease in plasma noradrenaline (P<0.05), which, thereafter, resumed the range of baseline values for 6 months. After patients had received CyA treatment for 1 month, the total power of systolic blood pressure variability and its low-frequency component remained higher than before treatment (P<0.05). At 3 and 6 months, heart rate was decreased (P<0.001) when high-frequency power of RR variability and plasma atrial natriuretic peptide were increased (P<0.05). As plasma noradrenaline never exceeded the baseline range, the hypertensive effect of CyA was not likely to have resulted from sympathetic activation. Rather, the increase in systolic blood pressure variability, its low-frequency component and the pattern of pulse pressure changes, pointed to a direct vascular effect of CyA. The maintenance of a normal cardiac baroreflex function during 6 months of CyA treatment might be pivotal to the adaptive responses towards direct CyA effects.
No takes yet. Share an insight, caveat, or question.
Bouhaddi et al. (2004) conducted an observational in High risk of rejection in corneal transplantation (n=8). Cyclosporine (CyA) vs. Baseline (before treatment) was evaluated on Autonomic cardiovascular control (blood pressure, heart rate, and variability) (p=<0.05). Cyclosporine treatment in corneal graft recipients increased systolic and diastolic blood pressures and systolic blood pressure variability, pointing to a direct vascular effect.
Synapse has enriched 10 related papers. Consider them for comparative context: